Hiroaki Tateno

7.0k total citations
194 papers, 5.5k citations indexed

About

Hiroaki Tateno is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Hiroaki Tateno has authored 194 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 153 papers in Molecular Biology, 95 papers in Immunology and 29 papers in Organic Chemistry. Recurrent topics in Hiroaki Tateno's work include Glycosylation and Glycoproteins Research (115 papers), Galectins and Cancer Biology (59 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). Hiroaki Tateno is often cited by papers focused on Glycosylation and Glycoproteins Research (115 papers), Galectins and Cancer Biology (59 papers) and Monoclonal and Polyclonal Antibodies Research (29 papers). Hiroaki Tateno collaborates with scholars based in Japan, United States and China. Hiroaki Tateno's co-authors include Jun Hirabayashi, Atsushi Kuno, Irwin Goldstein, Sachiko Nakamura‐Tsuruta, Tomohisa Ogawa, Koji Muramoto, Hisao Kamiya, James C. Paulson, Mineo Saneyoshi and Hisashi Narimatsu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Chemical Society Reviews.

In The Last Decade

Hiroaki Tateno

185 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hiroaki Tateno Japan 42 3.9k 2.5k 894 652 386 194 5.5k
Takashi Angata Taiwan 40 4.3k 1.1× 2.5k 1.0× 1.4k 1.5× 487 0.7× 565 1.5× 86 5.6k
Hans H. Wandall Denmark 46 5.0k 1.3× 2.0k 0.8× 1.2k 1.3× 994 1.5× 712 1.8× 125 6.7k
Sergey Y. Vakhrushev Denmark 38 3.7k 1.0× 1.1k 0.4× 919 1.0× 619 0.9× 462 1.2× 89 4.6k
Sandra Diaz United States 35 3.5k 0.9× 1.3k 0.5× 858 1.0× 788 1.2× 607 1.6× 65 5.2k
Hiren J. Joshi Denmark 28 3.0k 0.8× 914 0.4× 818 0.9× 362 0.6× 428 1.1× 48 3.8k
Thomas Gerken United States 36 3.1k 0.8× 1.0k 0.4× 1.2k 1.3× 450 0.7× 398 1.0× 91 4.1k
Margaret E. Huflejt United States 27 2.3k 0.6× 1.4k 0.6× 597 0.7× 514 0.8× 279 0.7× 41 3.5k
Åke Engström Sweden 47 4.8k 1.2× 2.4k 0.9× 230 0.3× 961 1.5× 442 1.1× 112 8.7k
Nico Callewaert Belgium 47 5.7k 1.5× 1.4k 0.5× 897 1.0× 1.2k 1.8× 743 1.9× 161 8.3k
Morten Thaysen‐Andersen Australia 38 3.3k 0.9× 928 0.4× 913 1.0× 544 0.8× 318 0.8× 108 4.1k

Countries citing papers authored by Hiroaki Tateno

Since Specialization
Citations

This map shows the geographic impact of Hiroaki Tateno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Tateno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Tateno more than expected).

Fields of papers citing papers by Hiroaki Tateno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroaki Tateno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Tateno. The network helps show where Hiroaki Tateno may publish in the future.

Co-authorship network of co-authors of Hiroaki Tateno

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Tateno. A scholar is included among the top collaborators of Hiroaki Tateno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Tateno. Hiroaki Tateno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tateno, Hiroaki, Lara K. Mahal, Ten Feizi, Carsten Kettner, & James C. Paulson. (2025). The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting lectin microarray data. Glycobiology. 35(4). 3 indexed citations
3.
Oda, Tatsuya, Osamu Shimomura, Yoshimasa Akashi, et al.. (2024). Aberrant Glycosylation in Pancreatic Ductal Adenocarcinoma 3D Organoids Is Mediated by KRAS Mutations. Journal of Oncology. 2024. 1–12.
4.
Arai, Junya, Yoku Hayakawa, Hiroaki Tateno, et al.. (2024). The role of gastric mucins and mucin‐related glycans in gastric cancers. Cancer Science. 115(9). 2853–2861. 8 indexed citations
5.
Oda, Tatsuya, Osamu Shimomura, Pakavarin Louphrasitthiphol, et al.. (2023). Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: 18F‐labeled rBC2LCN lectin. Cancer Science. 114(8). 3364–3373. 3 indexed citations
6.
Tateno, Hiroaki, et al.. (2022). Glycan profiling of the gut microbiota by Glycan-seq. ISME Communications. 2(1). 1–1. 11 indexed citations
7.
Yamasaki, Kazuhiko, Naruhiko Adachi, Mya Myat Ngwe Tun, et al.. (2022). Core fucose‐specific Pholiota squarrosa lectin ( PhoSL ) as a potent broad‐spectrum inhibitor of SARS‐CoV ‐2 infection. FEBS Journal. 290(2). 412–427. 9 indexed citations
8.
Hideshima, Sho, et al.. (2022). A Non‐Destructive Electrical Assay of Stem Cell Differentiation Based on Semiconductor Biosensing. Analysis & Sensing. 3(2). 3 indexed citations
9.
Mawaribuchi, Shuuji, Yoshikazu Haramoto, Hiroaki Tateno, et al.. (2020). rBC2LCN lectin as a potential probe of early‐stage HER2‐positive breast carcinoma. FEBS Open Bio. 10(6). 1056–1064. 9 indexed citations
10.
Watanabe, Tomoko, et al.. (2020). Monoclonal antibodies specific for podocalyxin expressed on human induced pluripotent stem cells. Biochemical and Biophysical Research Communications. 532(4). 647–654. 3 indexed citations
11.
Watanabe, Tomoko, et al.. (2020). SSEA-1-positive fibronectin is secreted by cells deviated from the undifferentiated state of human induced pluripotent stem cells. Biochemical and Biophysical Research Communications. 529(3). 575–581. 3 indexed citations
12.
Kanemaru, Kazumasa, Emiko Noguchi, Satoko Tahara‐Hanaoka, et al.. (2019). Clec10a regulates mite-induced dermatitis. Science Immunology. 4(42). 22 indexed citations
13.
Tateno, Hiroaki. (2019). Development of Lectin–Drug Conjugates for Elimination of Undifferentiated Cells and Cancer Therapy. Trends in Glycoscience and Glycotechnology. 31(183). E121–E127. 1 indexed citations
14.
Hirabayashi, Jun, Dan Hu, Hiroaki Tateno, et al.. (2018). Carbohydrate Recognition Mechanism of the Mushroom Galectin ACG. Trends in Glycoscience and Glycotechnology. 30(172). SE75–SE88. 1 indexed citations
15.
Hirabayashi, Jun, Dan Hu, Hiroaki Tateno, et al.. (2018). Carbohydrate Recognition Mechanism of the Mushroom Galectin ACG. Trends in Glycoscience and Glycotechnology. 30(172). SJ33–SJ46. 8 indexed citations
16.
Shimomura, Osamu, Tatsuya Oda, Hiroaki Tateno, et al.. (2017). A Novel Therapeutic Strategy for Pancreatic Cancer: Targeting Cell Surface Glycan Using rBC2LC-N Lectin–Drug Conjugate (LDC). Molecular Cancer Therapeutics. 17(1). 183–195. 42 indexed citations
17.
Tateno, Hiroaki & Jun Hirabayashi. (2014). The Cellular Glycome of Human Induced Pluripotent Stem Cells and Their Specific Probe rBC2LCN. Trends in Glycoscience and Glycotechnology. 26(147). 1–10. 1 indexed citations
18.
Onuma, Yasuko, Hiroaki Tateno, Shingo Tsuji, et al.. (2013). A Lectin-Based Glycomic Approach to Identify Characteristic Features of Xenopus Embryogenesis. PLoS ONE. 8(2). e56581–e56581. 6 indexed citations
19.
Tateno, Hiroaki, et al.. (2013). Terminal N-Acetylgalactosamine-Specific Leguminous Lectin from Wisteria japonica as a Probe for Human Lung Squamous Cell Carcinoma. PLoS ONE. 8(12). e83886–e83886. 15 indexed citations
20.
Yamasaki, Sho, Makoto Matsumoto, Osamu Takeuchi, et al.. (2009). C-type lectin Mincle is an activating receptor for pathogenic fungus, Malassezia. Proceedings of the National Academy of Sciences. 106(6). 1897–1902. 339 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takashi Angata Breakdown of academic impact, for papers by Hans H. Wandall Breakdown of academic impact, for papers by Sergey Y. Vakhrushev Breakdown of academic impact, for papers by Sandra Diaz Breakdown of academic impact, for papers by Hiren J. Joshi Breakdown of academic impact, for papers by Thomas Gerken Breakdown of academic impact, for papers by Margaret E. Huflejt Breakdown of academic impact, for papers by Åke Engström Breakdown of academic impact, for papers by Nico Callewaert Breakdown of academic impact, for papers by Morten Thaysen‐Andersen
Rankless by CCL
2026